Zhonglin Cai

823 citations
35 papers · 542 indexed · h-index 14
Topics
Sexual function and dysfunction studies (13 papers)Hormonal and reproductive studies (8 papers)RNA modifications and cancer (7 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zhonglin Cai

33 papers receiving 525 citations

Peers

Zhonglin Cai
Comparison fields: 5 of 103
  • Molecular Biology 187
  • Cancer Research 91
  • Endocrinology, Diabetes and Metabolism 71
  • Nutrition and Dietetics 69
  • Reproductive Medicine 69
Replace Daniele Lisboa Ribeiro with:
Daniele Lisboa Ribeiro Brazil
Hong‐I Chen Taiwan
Alaa-Eldin Salah-Eldin Egypt
Desanka Raskovic Italy
Yingchun Li China
Tomasz Pertyński Poland
Bishao Sun China
Linyan Lv China
Chhanda Gupta United States
Junping Xing China
Zhonglin Cai relative to Daniele Lisboa Ribeiro Brazil Daniele Lisboa Ribeiro's profile →
Citations per field
00.5×1.5×2.5×
Daniele Lisboa Ribeiro · 1×
Citations per year

Countries citing papers authored by Zhonglin Cai

Since Specialization
Citations

This map shows the geographic impact of Zhonglin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonglin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonglin Cai more than expected).

Fields of papers citing papers by Zhonglin Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonglin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonglin Cai. The network helps show where Zhonglin Cai may publish in the future.

Co-authorship network of co-authors of Zhonglin Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonglin Cai. A scholar is included among the top collaborators of Zhonglin Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonglin Cai. Zhonglin Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 6
5 17
6 6
7 0
8 2
9 5
10 37
11 6
12 38
13 6
14 13
15 39
16 5
17 15
18 19
19 10
20 11

About Zhonglin Cai

Zhonglin Cai is a scholar working on Psychiatry and Mental health, Reproductive Medicine and Urology, having authored 35 papers that have together received 542 indexed citations. Recurring topics across this work include Sexual function and dysfunction studies (13 papers), Hormonal and reproductive studies (8 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Reproductive Medicine (69 citations), Urology (43 citations) and Cancer Research (91 citations). Zhonglin Cai has collaborated with scholars based in China and United States. Frequent co-authors include Hongjun Li, Jianzhong Zhang, Chengquan Ma, Yamei Niu, Weijie Chen, Bin Yang, Fa Zhang, Jian Xiong, Xinyu Zhang and Bin Yang. Their work appears in journals such as Gene, Medicine and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026